Eamonn M M Quigley (E M M Quigley, Eamonn Mm Quigley, Eamonn Quigley)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 30

Top Venues

Alimentary pharmacology & therapeutics

Neurogastroenterology and motility

JGH open : an open access journal of gastroenterology and hepatology

Nature reviews. Gastroenterology & hepatology

Methodist Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Methodist Hospital Jan 15 2013

United States

Chief, Gastroenterology and Heaptology :: Medicine

University College Cork

Ireland

Professor and Gastroenterologist :: Medicine

University College Cork

Ireland

Dean :: School of Medicine

University of Nebraska Medical Center

United States

Chief, Division of Gastroenterology and Hepatology :: Medicine

University of Nebraska Medical Center

United States

Assistant/Associate/Professor :: Medicine

University of Manchester

United Kingdom

Lecturer in Medicine :: Medicine

Mayo Clinic

United States

Research Fellow :: Gastroenterology

Western Infirmary

United Kingdom

Senior House Officer and Registrar :: Medicine

St Finbarr's Hospital

Ireland

Intern :: Medicine and Surgery

Publications

Purna Kashyap, Paul Moayyedi, Eamonn M M Quigley, Magnus Simren, Stephen J Vanner
Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterology and motility 36 (6) (2024)
Purna Kashyap, Paul Moayyedi, Eamonn M M Quigley, Magnus Simren, Stephen J Vanner
Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterology and motility 36 (6) (2024)
Eamonn M M Quigley
Can diet change the natural history of gastrointestinal diseases? JGH open : an open access journal of gastroenterology and hepatology 8 (5) (2024)
Purna Kashyap, Paul Moayyedi, Eamonn M M Quigley, Magnus Simren, Stephen J Vanner
Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterology and motility 36 (6) (2024)
Anthony J Lembo, Madison Simons, Jack Loesch, Eyad Hamza, Erica Loren Graff, Eamonn M M Quigley, Satish S C Rao
Clinical trial: Effects of treatment with a vibrating capsule in patients with severe chronic constipation. Alimentary pharmacology & therapeutics (2024)
Purna Kashyap, Paul Moayyedi, Eamonn M M Quigley, Magnus Simren, Stephen J Vanner
Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterology and motility 36 (6) (2024)
Purna Kashyap, Paul Moayyedi, Eamonn M M Quigley, Magnus Simren, Stephen J Vanner
Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS). Neurogastroenterology and motility (2024)
Eamonn M M Quigley
Can diet change the natural history of gastrointestinal diseases? JGH open : an open access journal of gastroenterology and hepatology 8 (5) (2024)
Eamonn M M Quigley, Alex Stevenson, Ian Jeffery, Jacob Masters
Editorial: bacterial gut symbionts as live biotherapeutic agents in IBS-a rosy future despite potential long-term safety concerns. Authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Eamonn M M Quigley, Alex Stevenson, Ian Jeffery, Jacob Masters
Editorial: bacterial gut symbionts as live biotherapeutic agents in IBS-a rosy future despite potential long-term safety concerns. Authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Sabine Hazan, Neil Stollman, Huseyin S Bozkurt, Sonya Dave, Andreas J Papoutsis, Jordan Daniels, Brad D Barrows, Eamonn M M Quigley, Thomas J Borody
Lost microbes of COVID-19: Bifidobacterium , Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ open gastroenterology 9 (1) (2022)
Eamonn M M Quigley, Louise Markinson, Alex Stevenson, F Peter Treasure, Brian E Lacy
Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome. Alimentary pharmacology & therapeutics (2022)
Eamonn M M Quigley
Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome-wrong population, intervention, target or hypothesis? Alimentary pharmacology & therapeutics 56 (10) (2022)
Eamonn M M Quigley
Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean? Alimentary pharmacology & therapeutics 55 (9) (2022)
Seppo Salminen, Maria Carmen Collado, Akihito Endo, Colin Hill, Sarah Lebeer, Eamonn M M Quigley, Mary Ellen Sanders, Raanan Shamir, Jonathan R Swann, Hania Szajewska, Gabriel Vinderola
Reply to: Postbiotics - when simplification fails to clarify. Nature reviews. Gastroenterology & hepatology 18 (11) (2021)
Sandra Mohr, Nikola Fritz, Christian Hammer, Cristina Martínez, Sabrina Berens, Stefanie Schmitteckert, Verena Wahl, Malin Schmidt, Lesley A Houghton, Miriam Goebel-Stengel, Maria Kabisch, Dorothea Götze, Irina Milovač, Mauro D'Amato, Tenghao Zheng, Ralph Röth, Hubert Mönnikes, Felicitas Engel, Annika Gauss, Jonas Tesarz, Martin Raithel, Viola Andresen, Thomas Frieling, Jutta Keller, Christian Pehl, Christoph K Stein-Thoeringer, Gerard Clarke, Paul J Kennedy, John F Cryan, Timothy G Dinan, Eamonn M M Quigley, Robin C Spiller, Caroll Beltrán, Ana María Madrid, Verónica Torres, Rodrigo Quera, Wolfgang Herzog, Emeran A Mayer, Gregory S Sayuk, Maria Gazouli, George Karamanolis, Lejla Pojskić, Mariona Bustamante, Raquel Rabionet Janssen, Xavier Estivil, Andre Franke, Wolfgang Lieb, Guy E Boeckxstaens, Mira M Wouters, Magnus Simrén, Gudrun A Rappold, María Vicario, Javier Santos, Rainer Schaefert, Justo Lorenzo Bermejo, Beate Niesler
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome. Journal of cellular and molecular medicine 25 (16) (2021)
Seppo Salminen, Maria Carmen Collado, Akihito Endo, Colin Hill, Sarah Lebeer, Eamonn M M Quigley, Mary Ellen Sanders, Raanan Shamir, Jonathan R Swann, Hania Szajewska, Gabriel Vinderola
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nature reviews. Gastroenterology & hepatology 18 (9) (2021)
Eamonn M M Quigley
Nutraceuticals as modulators of gut microbiota: Role in therapy. British journal of pharmacology 177 (6) (2020)
Eamonn M M Quigley
Commentary: faecal microbiota transplantation-from home brew to holy grail. Alimentary pharmacology & therapeutics 51 (1) (2020)
John O'Grady, Eamonn M M Quigley
Editorial: the microbiome, aspirin and colorectal cancer. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Alexander Charles Ford, Lucinda A Harris, Brian E Lacy, Eamonn M M Quigley, Paul Moayyedi
Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply. Alimentary pharmacology & therapeutics 49 (9) (2020)
Eamonn M M Quigley, Prianka Gajula
Recent advances in modulating the microbiome. F1000Research 9 (2020)
Eamonn M M Quigley
Editorial: Lactobacillus GG for diarrhoea in children-reports of its demise have been premature! Alimentary pharmacology & therapeutics 49 (12) (2020)
Christopher J Black, Elyse R Thakur, Lesley A Houghton, Eamonn M M Quigley, Paul Moayyedi, Alexander Charles Ford
Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 69 (8) (2020)
Vineet S Gudsoorkar, Ayah Oglat, Amita Jain, Ali Raza, Eamonn M M Quigley
Systematic review with meta-analysis: cholecystectomy for biliary dyskinesia-what can the gallbladder ejection fraction tell us? Alimentary pharmacology & therapeutics 49 (6) (2019)
Michele Di Stefano, Eamonn M M Quigley
The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards? Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 30 (11) (2019)
Alexander Charles Ford, Lucinda A Harris, Brian E Lacy, Eamonn M M Quigley, Paul Moayyedi
Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Alimentary pharmacology & therapeutics 48 (10) (2018)
Eamonn M M Quigley
Editorial: diet, inflammation and irritable bowel syndrome. Alimentary pharmacology & therapeutics 45 (9) (2017)
Eamonn M M Quigley
Editorial: food for thought-the low-FODMAP diet and IBS in perspective. Alimentary pharmacology & therapeutics 46 (2) (2017)
Yan Yiannakou, J Tack, H Piessevaux, D Dubois, Eamonn M M Quigley, M Y Ke, S Da Silva, A Joseph, R Kerstens
The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference. Alimentary pharmacology & therapeutics 46 (11-12) (2017)
Eamonn M M Quigley
Prokinetics in the Management of Functional Gastrointestinal Disorders. Journal of neurogastroenterology and motility 21 (3) (2015)

Eamonn M M Quigley.css-eqlu8i{font-size:small;padding-left:4px;} (E M M Quigley, Eamonn Mm Quigley, Eamonn Quigley)

Publication Activity (10 Years)

Top Topics

Top Venues

Eamonn M M Quigley (E M M Quigley, Eamonn Mm Quigley, Eamonn Quigley)